Pharma-Bio Serv, Inc. · OTC:PBSV
Pharma-Bio Serv — Investor Presentation (December 2014)
17 slides from Pharma-Bio Serv's investor presentation, Dec 1, 2014
Slide 1: Corporate Presentation December 2014
INC. PHARMABIGRZERY CORPORATE PRESENTATION DECEMBER 2014
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-B
Slide 3: Core Business
Core Business Regulatory & Validation Compliance Consulting Quality Risk Management Technology Transfer Quality Systems Calibration BIO HSERV Validation & Complance INC Hood Validated Microbiological and Analytical Testing Field Support Method Development and Validation TENZALABS QUALITY TESTING SER
Slide 4: Comprehensive Support Services
Comprehensive Support Services PHARMA‘ ERV ~ State-of-the-art Multi-disciplinary Technical And Academ' Regulatory Standards Training and Knowledge ™ Management ia tegra tek ~ Microsoft Certified Partner Technology Consulting Practice Information Technology Ser Microsoft CERTIFIED
Slide 5: Investment Highlights
Investment Highlights + ¢ + % + Industry Leader In Regulatory Compliance Consulting Organic & Acquisition Growth Strategy 2M Share Buyback In Place $14M Cash On Balance Sheet Top Tier T. R. Winston & Company M & AAdvisory Team members include Michael Meyers, M.P.H., Managing Director and Head Of Inv
Slide 6: Key Statistics
Key Statistics Pharma-Bio Serv Inc. Stock Symbol: PBSV Exchange: OTC.QB Recent Price: $1.26 (11.26.14) 52-Week Range: $0.80 to $2.12 Shares Outst: 23M (09.11.14) Market Cap: $29M (11.26.14) 2013 Revenue $33M 2013 Net Income $4.9M Fiscal year End Oct 31 Industry: Regulatory Compliance Consulting Head
Slide 7: Recent Developments
Recent Developments ~ December 2014 — Retained T.R. Winston & Company to assist Pharma-Bio Serv in enhancing the Company’s growth strategy through business development and mergers and acquisitions. ~ October 2014 — Signed Strategic Collaboration Agreement With Quality Technical Iberica, S.L., suppor
Slide 8: Financial Highlights
Financial Highlights ~ Revenues of $20.4M, Net Income of $1.6 million for the nine months ended July 31, 2014, a decrease of $3.9M and $2.1M respectively vs. 2013. ~ Record total net revenues of $33.1 million for the year ended October 31, 2013, an increase of approximately $3.8 million, or 13% vs.
Slide 9: Historical Perspective
Historical Perspective ~ Exceptional Corporate Management Culture ~ Never Experienced A Losing Quarter 30,000 000. Revenues- All Divisions
Slide 10: Validation & Compliance Consulting
Validation & Compliance Consulting
Slide 11: Validation & Compliance Consulting
Validation & Compliance Consulting Clients include: Y 8 of the Top 10 Global Bio-Pharma Companies Y 7 ofthe Top 10 Global Medical Technology Companies ~ Recognized for 10 consecutive years as one of the top Validation & Compliance Service companies in Puerto Rico by Caribbean Business. ~ Offices in
Slide 12: Validation & Compliance Consulting
Validation & Compliance Consulting £ ro . Global Life Sciences Industry Leader In Regulatory Compliance _ And Other Regulated Industry Support Services. services FDA and International agencies regulatory compliance related ~+ Pharmaceutical ~ Biotechnology + Chemical ~+ Medical Device + Cosmetic ~ F
Slide 13: Global Growth Strategy
Global Growth Strategy ~ Provide Additional Regulatory Compliance Services in U.S., South America & European Markets Organically And Through Strategic Acquisition ~ Expand Geographic Reach Organically And Through Strategic Acquisition ~ Invest In U.S., South America & European Infrastructure And Tal
Slide 14: Differentiators
Differentiators ~ In June 2011, Pharma-Bio Serv obtained a new Grant of Industrial Tax Exemption pursuant to the terms and conditions set forth in Act No. 73 of May 28, 2008 (“the Grant”) issued by the Puerto Rico Industrial Development Company (‘PRIDCO’). ~ The Grant provides relief on various Puer
Slide 15: Track Record of Success
Track Record of Success — ke= 6K, Our Global Offices Trusted Validation Project Services Partner ~ Excellent Track Record of Success ~ Key certifications Over 20 Years of Experience ~ Successful Management Team ~ Headcount: 245 ~ HQ in Puerto Rico with offices in U.S., Ireland and Spain 2008 Recogni
Slide 16: Esteemed Management and Board of Directors
Esteemed Management and Board of Directors ~ Elizabeth Plaza - Principal Executive Officer, Chairman of the Board since 2006 ~ Pedro J. Lasanta - Chief Financial Officer and Vice President - Finance and Administration since 2007 ~ Kirk Michel - Director since 2006 ~ Dov Perlysky - Director since 200
Slide 17: For More Information
For More Information Investor Relations Scott Gordon, President CorProminence 377 Oak Street Concourse 2 Garden City, NY 11530 Office: 631.703.4900 Email: [email protected] DORADO, PR, USA +1 787 278 2709 PLYMOUTH MEETING, PA, USA +1 215 997 3310 CALIFORNIA AND U.S. WEST Coast, USA +4310 426
Pharma-Bio Serv — Investor Presentation (December 2014) on 6ix